These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10508016)

  • 21. Pharmacokinetics of isepamicin following a single administration by intravenous infusion or intramuscular injections.
    Radwanski E; Batra V; Cayen M; Korduba C; Cutler D; Affrime M; Nomeir A; Lin CC
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1794-6. PubMed ID: 9257763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetic analysis of new aminoglycosides, astromicin and isepamicin, and evaluation of Bayesian prediction method for approximation of individual clearance of drug.
    Uematsu T
    Int J Clin Pharmacol Ther Toxicol; 1993 Dec; 31(12):606-10. PubMed ID: 8314363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of intravenous piperacillin administration in patients undergoing on-line hemodiafiltration.
    Oh KH; Kim C; Lee H; Lee H; Jung JY; Kim NJ; Yu KS; Shin KH; Jang IJ; Ahn C
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3266-8. PubMed ID: 19451284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffusion of isepamicin into cancellous and cortical bone tissue.
    Boselli E; Breilh D; Bel JC; Debon R; Saux MC; Chassard D; Allaouchiche B
    J Chemother; 2002 Aug; 14(4):361-5. PubMed ID: 12420853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High variability of teicoplanin concentration in patients with continuous venovenous hemodiafiltration.
    Lim SK; Lee SA; Kim CW; Kang E; Choi YH; Park I
    Hemodial Int; 2019 Jan; 23(1):69-76. PubMed ID: 30714672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of moxifloxacin in patients undergoing continuous venovenous haemodiafiltration.
    Fuhrmann V; Schenk P; Jaeger W; Ahmed S; Thalhammer F
    J Antimicrob Chemother; 2004 Oct; 54(4):780-4. PubMed ID: 15347636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of intramuscularly administered isepamicin in man.
    Lin CC; Radwanski E; Korduba C; Affrime M; Cayen MN
    Chemotherapy; 1997; 43(2):86-93. PubMed ID: 9084916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of intravenously administered isepamicin in men.
    Lin CC; Radwanski E; Korduba C; Cayen M; Affrime M
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2774-8. PubMed ID: 8593018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of isepamicin in paediatric patients.
    Scaglione F; Viganò A; Colucci R; Zampaglione N; Lin CC; Cutler D; Guerciolini R; Elliott M; Affrime M; Radwanski E
    J Chemother; 1995 Jun; 7 Suppl 2():63-9. PubMed ID: 8622112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients.
    Fish DN; Teitelbaum I; Abraham E
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2421-8. PubMed ID: 15917542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Key pharmacokinetic parameters of isepamicin in febrile neutropenic cancer patients and in women with acute pelvic inflammatory disease.
    Yombi JC; Wallemacq P; Leal T; Gala JL; Vandercam B
    J Chemother; 2005 Oct; 17(5):521-6. PubMed ID: 16323441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation.
    Mariat C; Venet C; Jehl F; Mwewa S; Lazarevic V; Diconne E; Fonsale N; Carricajo A; Guyomarc'h S; Vermesch R; Aubert G; Bidault R; Bertrand JC; Zeni F
    Crit Care; 2006 Feb; 10(1):R26. PubMed ID: 16507147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isepamicin disposition in subjects with various degrees of renal function.
    Halstenson CE; Kelloway JS; Affrime MB; Lin CC; Teal MA; Shapiro BE; Awni WM
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2382-7. PubMed ID: 1804011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors affecting serum concentration of vancomycin in critically ill oliguric pediatric patients receiving continuous venovenous hemodiafiltration.
    Lee B; Kim SJ; Park JD; Park J; Jung AH; Jung SH; Choi YH; Kang HG; Ha IS; Cheong HI
    PLoS One; 2018; 13(6):e0199158. PubMed ID: 29927988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and Dialytic Clearance of Ceftazidime-Avibactam in a Critically Ill Patient on Continuous Venovenous Hemofiltration.
    Wenzler E; Bunnell KL; Bleasdale SC; Benken S; Danziger LH; Rodvold KA
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28416553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colistin pharmacokinetics in intensive care unit patients on continuous venovenous haemodiafiltration: an observational study.
    Markou N; Fousteri M; Markantonis SL; Zidianakis B; Hroni D; Boutzouka E; Baltopoulos G
    J Antimicrob Chemother; 2012 Oct; 67(10):2459-62. PubMed ID: 22790220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population pharmacokinetics of linezolid in critically ill patients on renal replacement therapy: comparison of equal doses in continuous venovenous haemofiltration and continuous venovenous haemodiafiltration.
    Roger C; Muller L; Wallis SC; Louart B; Saissi G; Lipman J; Lefrant JY; Roberts JA
    J Antimicrob Chemother; 2016 Feb; 71(2):464-70. PubMed ID: 26538503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and clearance of ganciclovir during continuous hemodiafiltration.
    Gando S; Kameue T; Nanzaki S; Hayakawa T; Nakanishi Y
    Crit Care Med; 1998 Jan; 26(1):184-7. PubMed ID: 9428565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doripenem pharmacokinetics in critically ill patients receiving continuous hemodiafiltration (CHDF).
    Hidaka S; Goto K; Hagiwara S; Iwasaka H; Noguchi T
    Yakugaku Zasshi; 2010 Jan; 130(1):87-94. PubMed ID: 20046071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bayesian pharmacokinetics of gentamicin in a haemodialysis population.
    Vercaigne LM; Ariano RE; Zacharias JM
    Clin Pharmacokinet; 2004; 43(3):205-10. PubMed ID: 14871157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.